Rafael Holdings, Inc. (RFL): Capital Expenditures
$3.0K
Year ended 2026-07-31
-57.1%
5-year compound annual growth
-46.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2026-07-31 | $3.0K | -25.0% | 2026-10-29, From 2025-08-01 |
| 2025-07-31 | $4.0K | -97.2% | 2026-10-29, From 2024-08-01 |
| 2024-07-31 | $143.0K | n/a | 2025-10-29, From 2023-08-01 |
| No annual figure between 2022-07-31 and 2024-07-31. | |||
| 2022-07-31 | $2.0K | -99.0% | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | $206.0K | -61.4% | 2021-10-18, From 2020-08-01 |
| 2020-07-31 | $534.0K | +33.8% | 2021-10-18, From 2019-08-01 |
| 2019-07-31 | $399.0K | -43.8% | 2020-10-29, From 2018-08-01 |
| 2018-07-31 | $710.0K | -61.0% | 2019-10-04, From 2017-08-01 |
| 2017-07-31 | $1.82M | +17.2% | 2018-10-15, From 2016-08-01 |
| 2016-07-31 | $1.55M | n/a | 2018-10-15, From 2015-08-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | 2026-07-31 | $3.0K | -25.0% |
| Shattuck Labs, Inc. (STTK) | 2025-12-31 | $71.0K | +20.3% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP) | 2025-12-31 | $139.9K | +34.8% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $385.3K | -32.8% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $24.6K | -42.7% |
| BioXcel Therapeutics, Inc. (BTAIQ) | 2025-12-31 | $0 | n/a |
| Longeveron Inc. (LGVN) | 2025-12-31 | $245.0K | -62.6% |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $442.3K | n/m |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $0 | -100.0% |
Compare RFL, STTK, SXTP, DARE side by side · Screen every company in Pharmaceutical Preparations ↗